Decentralized Intelligence Part 3: The Insights You Can’t Get Alone

This post is Part 3 of a four-part blog series, Decentralized Intelligence. Part 2 laid out the architecture of federated computing. Here, we get into the payoff — the kinds of insights federated intelligence networks make possible, and why the value grows the longer you participate.

Every organization has a question it can't answer but desperately wants to. Not because the analytical capability doesn't exist, but because the data that would answer cannot travel to a central location due to privacy, regulatory, or governance concerns. Does this failure mode show up across our other plants, or just this one? Which molecular targets are actually predictive of response across all the trial sites? What fraud pattern is the whole network seeing that no single institution can detect on its own?

Federated intelligence networks change the questions you can ask of the data because the data stays where it is. The organizations building these networks aren’t just getting better answers — they’re also building a capability that compounds as the network grows.

Here's where that value actually shows up.

How Organizations Build and Join

Organizations enter federated intelligence networks either as a builder or as a participant.

A network builder organizes the collaboration: its purpose, participation rules, shared infrastructure, and definition of success. A participant contributes relevant data, models, compute, or expertise and gains access to capabilities it could not readily create alone. These roles are not necessarily mutually exclusive, as an organization can help build a network and participate in it.

Lilly TuneLab illustrates this value exchange in practice. Lilly made AI models developed through its own research investment available to external biotechs, and in the twelve months since its launch, the program has surpassed 125 members. Its federated infrastructure allows Lilly to share its models without sharing the underlying training data, while selected biotech partners contribute to further model development without directly exposing their proprietary compounds or datasets to Lilly or other members. Lilly uses these contributions to develop subsequent model versions through federated learning, and participants gain access to the improved models.

A biotech participant gets predictive capabilities applied to its own candidates without reproducing the research investment behind the models. For the builder, the value is an ecosystem in which models reach more users and approved partner contributions support continued learning.

The Cancer AI Alliance (CAIA) — founded by Dana-Farber, Fred Hutch, Memorial Sloan Kettering, and Johns Hopkins’ Sidney Kimmel Comprehensive Cancer Center — illustrates the value of participation in a research consortium. Its members train models across participating institutions’ clinical data without accessing one another’s patient records.

Participants gain faster time to value and access to a broader data network. Onboarding takes weeks rather than quarters, and they do not have to recruit the network themselves. They start with an established schema, quality-reviewed data, and readily available tools for data harmonization, preprocessing, model training, and evaluation.

The choice between building and joining comes down to what an organization owns and what it needs. Join a network to benefit from what is already established and learn what governance costs in practice, without bearing the full burden yourself. Build one when you own a question no existing network is asking and can credibly recruit the sites holding the complementary data.

Three Questions Federated Intelligence Networks Can Help Answer

The clearest way to see what these networks make possible is to look at the questions they unlock and who's asking them.

1. How does this pattern compare across all of our sites?

A manufacturer running plants across three countries wants to know how raw material batch variation correlates with downstream defect rates. The data exists inside each plant. None of it is going to a central lake. With a federated intelligence network, the analysis runs locally at each site and the insight comes back so that two years of accumulated operational data is now answerable in a single query.

A pharmaceutical sponsor running a trial across forty sites faces the same pattern at higher stakes. Which patient characteristics predict response? Is an emerging safety signal real, or an artifact of one site's population? The answers require pooling evidence across every site, but trial data is rarely centralized and often can't be. A federated intelligence network runs the analysis locally and returns validated, pooled results with site-level caveats intact.

2. What is the whole network seeing that no single participant can?

Four cancer centers can train models across millions of patient records without any institution accessing another's raw, sensitive data. A network of banks can identify fraud typologies that only become visible across the full transaction graph. The intelligence each participant receives is richer than anything they could produce from their own data alone.

This is particularly valuable for questions involving rare cancers and smaller patient groups where a single institution may have limited relevant cases. Learning across institutions also allows researchers to test whether findings extend beyond one center’s population. The network brings complementary evidence to consequential questions: Are enough relevant cases available to study? Does the model hold up across participating populations? Can weaknesses be identified before broader use?

3. How do we build a model that keeps getting better after it ships?

An industrial AI company ships a baseline model to hundreds of factory deployments. Each factory runs it against local operational data. Validated improvements flow back. The customer keeps proprietary operational context under local control, and the vendor ships a product that improves continuously rather than depreciating between release cycles.

Lilly’s TuneLab is the pharma version of the same pattern: the model provider's training data stays private, the tuner's compounds stay private, and both sides get a better model than either could produce alone.

The questions look different across industries. What changes in every case is the scale at which the network can reason, far beyond what any single participant could manage alone.

From AI Tool to AI Colleague

The next step is to connect federated AI with federated actions.

Most organizations are building toward a version of enterprise AI that reasons, decides, and acts across the full complexity of an operational environment. That's the promise of agentic AI. 

An agent operating in a real production environment needs live access to the systems where work actually happens, such as the maintenance log that tracks equipment history, the manufacturing execution system that reflects what's running right now, or the operational exception queue that tells it where attention is needed. A static, centralized data extract can tell an agent what happened last quarter. Live operational access lets it determine what to do next.

That's the context a federated intelligence network provides. The federated element is the coordination across independently governed environments and sandboxes. In practice, it enables agents to work across four distinct modes:

• Ideation partner: Pressure-testing a proposed line redesign against historical performance data before it reaches the floor
• Critical reviewer: Flagging gaps in a model rollout plan— a missing variable, a weak sampling strategy — before it reaches production
• Specialist collaborator: Designing within constraints by selecting parameters and running tests across a digital twin
• Autonomous operator: Running bounded daily workflows like shift handoffs, work-order creation, and exception escalation

An agent that can only see sanitized, stale data can't operate in any of these modes meaningfully. The federated network piece is what gives it the context to be genuinely useful.

The Network Effect

Federated intelligence networks get more valuable as they grow. 

A new participant might contribute a patient population, operating condition, or failure mode the existing network doesn't adequately represent, broadening what the models can see and answer. Validated results create opportunities to refine shared models and workflows. The best part? The work compounds: reviewed data mappings, permissions, execution paths, and governance structures carry forward to support subsequent projects rather than being rebuilt from scratch.

Early builders and participants also get to shape the governance and business rules before they calcify and to develop real operational experience in the process.

Rhino Federated Intelligence is the infrastructure organizations use to build and participate in these networks. If your organization is sitting on data it can't use, or trying to answer questions it can't centralize, book a demo to talk with our team.

In our next installment, we'll explore the frontier questions that federated intelligence networks haven't fully solved yet and what answering them would make possible.

This post is Part 3 of a four-part blog series, Decentralized Intelligence, publishing every two weeks.